The Claim
Serum uric acid levels in patients with tophaceous gout decreased from an average of 8.39 mg/dL at baseline to 4.92 mg/dL after approximately 3.8 years of uric acid-lowering therapy, with substantial individual variability in response.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with tophaceous gout, serum uric acid levels dropped from an average of 8.39 mg/dL to 4.92 mg/dL after 3.8 years of uric acid-lowering therapy, though responses varied widely among individuals.
See the scientific wording
Serum uric acid levels in patients with tophaceous gout decreased from an average of 8.39 mg/dL at baseline to 4.92 mg/dL after approximately 3.8 years of uric acid-lowering therapy, with substantial individual variability in response.
When uric acid levels in the blood drop below a certain point, the crystals that formed in joints and tissues start to dissolve. These dissolved crystals are then eaten up and removed by immune cells in the body, leading to smaller tophi and lower overall uric acid levels.
What the research says
1 studyThe study found that in men with advanced gout, blood uric acid levels went down from 8.4 to 4.9 mg/dL after nearly four years of treatment — just like the claim says. Some people’s levels dropped more than others, which the study also confirms.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.